Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials

INTRODUCTION: Myasthenia gravis (MG), a rare neuromuscular disease, is often initially treated using acetylcholinesterase inhibitors. Patients who do not respond adequately depend on the use of corticosteroids or other immunosuppressive medication, but these may have serious side effects. Clinical o...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Open
Main Authors: Vrinten, Charlotte, Lipka, Alexander F, van Zwet, Erik W, Schimmel, Kirsten J M, Cornel, Martina C, Kuijpers, Marja R, Hekster, Yechiel A, Weinreich, Stephanie S, Verschuuren, Jan J G M
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2015
Subjects:
Neurology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4513481/
https://ncbi.nlm.nih.gov/pubmed/26185179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-007863
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items